摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-[4-(3-hydroxyisoxazol-5-yl)phenyl]-N-(3-isopropoxybenzyl)-N-methylethanamine trifluoroacetate | 1198744-64-7

中文名称
——
中文别名
——
英文名称
1-[4-(3-hydroxyisoxazol-5-yl)phenyl]-N-(3-isopropoxybenzyl)-N-methylethanamine trifluoroacetate
英文别名
5-[4-[1-[Methyl-[(3-propan-2-yloxyphenyl)methyl]amino]ethyl]phenyl]-1,2-oxazol-3-one;2,2,2-trifluoroacetic acid
1-[4-(3-hydroxyisoxazol-5-yl)phenyl]-N-(3-isopropoxybenzyl)-N-methylethanamine trifluoroacetate化学式
CAS
1198744-64-7
化学式
C2HF3O2*C22H26N2O3
mdl
——
分子量
480.484
InChiKey
WTQMAGDKAAKIQV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.66
  • 重原子数:
    34
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    88.1
  • 氢给体数:
    2
  • 氢受体数:
    9

文献信息

  • NOVEL ISOXAZOLE DRIVATIVE
    申请人:Ishikawa Makoto
    公开号:US20110065739A1
    公开(公告)日:2011-03-17
    Disclosed is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, which has an agonistic activity on GPR120 and is therefore useful for the treatment of diabetes, obesity or hyperlipemia. [In formula (I), the A represents a phenyl group which may be substituted by a lower alkoxy group or the like; the 13 represents a bivalent group produced by removing two hydrogen atoms from a benzene ring which may be substituted by a halogen atom or the like; X represents a lower alkylene group having 2 to 4 carbon atoms in its main chain or the like, wherein a carbon atom constituting the main chain may be substituted by an oxygen atom or the like; and Y represents a hydrogen atom or the like.]
    揭示了一种由式(I)表示的化合物或其药学上可接受的盐,该化合物对GPR120具有激动活性,因此对于治疗糖尿病、肥胖或高脂血症是有用的。【在式(I)中,A代表可能被低烷氧基或类似物取代的苯基;13代表通过从苯环中去除两个氢原子而产生的二价基团,该苯环可能被卤素原子或类似物取代;X代表具有2至4个碳原子的低烷基基团或类似物,其中构成主链的碳原子可能被氧原子或类似物取代;Y代表氢原子或类似物。】
  • NOVEL ISOXAZOLE DERIVATIVE
    申请人:MSD K.K.
    公开号:EP2298750A1
    公开(公告)日:2011-03-23
    Disclosed is a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, which has an agonistic activity on GPR120 and is therefore useful for the treatment of diabetes, obesity or hyperlipemia. [In formula (I), the A represents a phenyl group which may be substituted by a lower alkoxy group or the like, or the like; the B represents a bivalent group produced by removing two hydrogen atoms from a benzene ring which may be substituted by a halogen atom or the like, or the like; X represents a lower alkylene group having 2 to 4 carbon atoms in its main chain or the like, wherein a carbon atom constituting the main chain may be substituted by an oxygen atom or the like; and Y represents a hydrogen atom or the like.]
    本发明公开了一种由式(I)代表的化合物或其药学上可接受的盐,该化合物对 GPR120 具有激动活性,因此可用于治疗糖尿病、肥胖症或高脂血症。式(I)中,A 代表苯基,可被低级烷氧基等取代;B 代表二价基团,通过从苯环中去除两个氢原子而产生,可被卤素原子等取代;X 代表低级亚烷基,其主链上有 2 至 4 个碳原子等,其中构成主链的一个碳原子可被氧原子等取代;Y 代表氢原子等。
查看更多